IRIS
MAGLIANI, Valter
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.878
AS - Asia 11.615
EU - Europa 8.541
SA - Sud America 2.092
AF - Africa 701
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 5
Totale 34.854
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.493
SG - Singapore 4.342
CN - Cina 3.559
VN - Vietnam 1.959
BR - Brasile 1.645
UA - Ucraina 1.492
DE - Germania 1.326
IE - Irlanda 1.310
FI - Finlandia 1.068
IT - Italia 920
SE - Svezia 892
HK - Hong Kong 832
ZA - Sudafrica 523
FR - Francia 403
NL - Olanda 401
CA - Canada 277
TR - Turchia 204
GB - Regno Unito 180
AR - Argentina 170
RU - Federazione Russa 154
AT - Austria 143
IN - India 113
EC - Ecuador 103
BD - Bangladesh 95
JP - Giappone 73
IQ - Iraq 71
MX - Messico 68
ID - Indonesia 54
ES - Italia 50
BE - Belgio 44
CO - Colombia 44
MA - Marocco 41
PL - Polonia 41
PY - Paraguay 37
PK - Pakistan 34
KE - Kenya 32
VE - Venezuela 32
PH - Filippine 31
EG - Egitto 27
CL - Cile 26
KR - Corea 25
UZ - Uzbekistan 23
JO - Giordania 22
TN - Tunisia 22
TW - Taiwan 22
TH - Thailandia 21
RO - Romania 20
SA - Arabia Saudita 20
EU - Europa 19
AZ - Azerbaigian 15
IL - Israele 15
KZ - Kazakistan 15
UY - Uruguay 15
AE - Emirati Arabi Uniti 13
CZ - Repubblica Ceca 13
LT - Lituania 13
NP - Nepal 13
ET - Etiopia 11
CI - Costa d'Avorio 10
BO - Bolivia 9
BG - Bulgaria 8
OM - Oman 8
PE - Perù 8
CH - Svizzera 7
TT - Trinidad e Tobago 7
AL - Albania 6
DZ - Algeria 6
HN - Honduras 6
CR - Costa Rica 5
HU - Ungheria 5
IR - Iran 5
LB - Libano 5
RS - Serbia 5
BA - Bosnia-Erzegovina 4
BB - Barbados 4
BY - Bielorussia 4
EE - Estonia 4
JM - Giamaica 4
NG - Nigeria 4
NI - Nicaragua 4
PS - Palestinian Territory 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
AO - Angola 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
GE - Georgia 3
HR - Croazia 3
LU - Lussemburgo 3
LV - Lettonia 3
MD - Moldavia 3
NZ - Nuova Zelanda 3
XK - ???statistics.table.value.countryCode.XK??? 3
ZW - Zimbabwe 3
AM - Armenia 2
AU - Australia 2
BW - Botswana 2
GR - Grecia 2
GY - Guiana 2
Totale 34.813
Salva come PNG Salva come JPEG
Città #
Singapore 1.893
Jacksonville 1.542
Dublin 1.306
San Jose 1.130
Ashburn 1.043
Chandler 1.006
Beijing 960
Hong Kong 804
Dearborn 762
Ho Chi Minh City 627
Santa Clara 515
Boardman 498
Johannesburg 494
Nanjing 486
Hanoi 448
Dallas 401
Princeton 365
Lauterbourg 318
Ann Arbor 286
San Mateo 285
Munich 261
Toronto 208
Wilmington 207
Parma 178
Helsinki 171
Kunming 171
Bremen 167
New York 166
Shenyang 155
Hefei 154
Izmir 152
Nanchang 139
Los Angeles 138
Vienna 131
São Paulo 127
Hebei 118
Shanghai 117
Moscow 116
Des Moines 101
Jinan 95
Da Nang 83
Haiphong 81
Tianjin 72
Grafing 68
Buffalo 65
Jiaxing 63
Changsha 58
Guangzhou 58
Rio de Janeiro 57
Woodbridge 51
Seattle 48
Norwalk 47
Turku 47
Rome 44
Brussels 42
Tokyo 42
Fortaleza 41
Columbus 40
Brasília 38
Düsseldorf 37
Frankfurt am Main 36
Biên Hòa 35
Fremont 34
Warsaw 34
Zhengzhou 34
Hải Dương 32
Marseille 32
Quito 32
Bắc Ninh 31
Hangzhou 31
Council Bluffs 30
Guayaquil 30
Baghdad 28
Brooklyn 28
Houston 28
Orem 27
Milan 26
Nairobi 26
Can Tho 25
Atlanta 24
Chengdu 24
Salvador 24
Chennai 23
Porto Alegre 23
Thái Bình 23
Belo Horizonte 22
The Dalles 22
Curitiba 21
Amman 20
Fuzhou 20
Campinas 19
Chicago 19
Montreal 19
Nuremberg 19
Tashkent 19
Denver 18
Jakarta 18
Ningbo 18
San Francisco 18
Boston 17
Totale 20.332
Salva come PNG Salva come JPEG
Nome #
A transphyletic anti-infectious control strategy based on the killer phenomenon. 281
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 241
Capitolo 5. Differenziamento reale e differenziamento temporaneo. 231
Anaflatoxin B1 as the Paradigm of a New Class of Vaccines Based on “Mycotoxoids” 227
Novel activity of a synthetic decapeptide against Toxoplasma gondii Tachyzoites 210
Dissecting the structure-function relationship of a fungicidal peptide derived from the constant region of human immunoglobulins 200
Anti-infective antibody-derived peptides active against endogenous and exogenous fungi 200
In vitro and in vivo anti-Candida activity and structural analysis of killer peptide (KP)-derivatives 196
Antibodies as a source of anti-infective peptides: an update 189
A peptide found in human serum, derived from the c-terminus of albumin, shows antifungal activity in vitro and in vivo 186
Antifungal properties of newly designed carbonic anhydrases inhibitors selective for microbial enzymes 185
A synthetic peptide as a novel anticryptococcal agent 182
Analisi dell’attività fungicida di un peptide derivato dalla regione costante di immunoglobuline M umane 180
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 174
Metabolic profiling of Candida albicans 173
AFM1 in Milk: Physical, Biological, and Prophylactic Methods to Mitigate Contamination 172
Antifungal peptides within the antibodies 170
A Naturally Occurring Antibody Fragment Neutralizes Infectivity of Diverse Infectious Agents 167
Screening of thiosemicarbazones as antimycotic drugs 167
An engineered anti-idiotypic antibody-derived killer peptide (KP) early activates swine inflammatory monocytes, CD3+CD16+ natural killer T cells and CD4+CD8α+ double positive CD8β+ cytotoxic T lymphocytes associated with TNF-α and IFN-γ secretion 166
Fungicidal activity of peptides encoded by immunoglobulin genes 165
Peptides of the Constant Region of Antibodies Display Fungicidal Activity 165
Antifungal activity of the C-terminal peptide from human serum albumin 162
Anti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies 162
Phenotypic modulation of porcine CD14+ monocytes, natural killer/natural killer T cells and CD8αβ+ T cell subsets by an antibody-derived killer peptide (KP) 160
Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases 160
Cap. 6. Differenziamento reale e differenziamento temporaneo. 157
Antibody constant region peptides can display immunomodulatory activity through activation of the Dectin-1 signalling pathway. 157
L'identificazione dei batteri Gram negativi mediante il sistema ATB. 155
Antibody peptide based antifungal immunotherapy 153
Peptides from the inside of the antibodies are active against infectious agents and tumours 152
Antibody Complementarity-Determining Regions (CDRs): A Bridge between Adaptive and Innate Immunity 151
Antibodies as unlimited source of anti-infective, anti-tumor and immunomodulatory peptides 150
Anti-septic shock recombinant vaccine. 150
Antimicrobial activity of poultry bone and meat trimmings hydrolyzates in low-sodium turkey food 149
Antibody-mediated protective immunity in fungal infections 149
Anticorpi antibiotici antiidiotipo immagini interne di tossine killer. 149
Activity of an engineered synthetic killer peptide on Leishmania major and Leishmania infantum promastigotes. 148
Anticorpi immagini interne di tossine killer 148
Natural and synthetic peptides with antifungal activity 147
Agenti virali di gastroenterite. 144
Antibiobodies: antibiotic-like antiidiotypic antibodies. 144
Selective miRNA down-regulation in the inhibition of HIV-1 replication by a human serum antibody-derived peptide 140
Antimicrobial peptides with antiprotozoal activity: Current state and future perspectives 140
Antibiocorpi: anticorpi antiidiotipo ad attività antibiotica e profilattica. 138
Anticorpi antibiotici ricombinanti ad attività terapeutica fungicida. 137
Vaccination of lactating dairy cows for the prevention of Aflatoxin B1 carry over in milk 136
Yeast killer toxin-like candidacidal Ab6 antibodies elicited through the manipulation of the idiotypic cascade 136
Antireceptor yeast killer toxin-like antibiobodies 135
Mode of action of a killer peptide against Toxoplasma gondii 135
Antibiobodies: antibiotic internal image antibodies 134
Killer peptide: a novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs 134
A killer mimotope with therapeutic activity against AIDS-related opportunistic microorganisms inhibits ex vivo HIV-1 replication 134
Anticorpi antiidiotipici ricombinanti ad attività terapeutica fungicida. 132
In vitro activity of killer peptide against Toxoplasma gondii tachyzoites 132
Metabolic profile of Candida albicans 131
Dissection of the Structural Features of a Fungicidal Antibody-Derived Peptide 131
Wickerhamomyces yeast killer toxins’ medical applications 130
Attività in vitro e in vivo nei confronti di Candida albicans di peptidi sintetici progettati in silico 129
Significato diagnostico di IgA secretorie adese a cellule lievitiformi nelle candidosi orali 129
Attività terapeutica di un peptide sintetico killer nei confronti di virus influenzali 128
Metabolic Plasticity of Candida albicans in Response to Different Environmental Conditions 127
Production of an engineered killer peptide in Nicotiana benthamiana by using a Potato virus X expression system 126
Antibiotic antibodies 125
Therapeutic Activity of an Anti-Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection 124
Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation 124
In vitro and in vivo anticandidal activity of killer peptide derivatives 124
In silico predicted antifungal peptides: In vitro and in vivo anti-candida activity 124
Therapeutic activity of a killer peptide against experimental paracoccidioidomycosis 123
Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins 123
Il sistema immunoenzimatico GM1 ELISA per la ricerca della tossina termolabile di E. coli. 122
Innate antimicrobial and antiviral activities of antibody peptides 122
Attività terapeutica di un peptide sintetico killer nei confronti di virus influenzali aviari ed umani. 120
Development of a novel paratransgenic symbiotic-based control strategy for vector-borne infectious diseases 120
Restriction of Influenza virus multiplication induced by PK peptide treatment 118
Caratterizzazione di mannoproteine da stress di Candida albicans reattive con IgA secretorie 117
Inibizione della replicazione di virus influenzali mediante trattamento di cellule infette con un peptide sintetico killer 113
Antibodies as Crypts of Antiinfective and Antitumor Peptides 112
Inhibition performed by a synthetic microbicidal peptide on the replication of Influenza virus. Abstract 21.009 112
Idiotypic antifungal vaccination: Immunoprotection by antiidiotypic antibiotic antibodies 112
Clonaggio e sequenziamento dei geni codificanti per la tossina killer di Pichia anomala 111
Candidacidal properties of peptides encoded by immunoglobulin genes 111
Applicazioni della Biologia Molecolare in Micologia. 110
L'elettroferotipo come mezzo di indagine epidemiologica nelle gastroenteriti da rotavirus umani. 110
Valutazione di un nuovo sistema automatizzato per l'identificazione e l'antibiogramma: L'identificazione rapida. Workshop: Recenti sviluppi e nuove prospettive dei metodi automatizzati per l'identificazione e l'antibiogramma. 109
Any antibody fragment might exert antifungal activity 109
Valutazione di alcuni aspetti della nuova tecnologia VITEK2 effettuata presso gli Istituti di Microbiologia dell'Università di Parma e dell'Università Cattolica di Roma. Workshop: VITEK2: un mondo d'innovazione. 109
Therapeutic potential of yeast killer toxin-like antibodies and mimotopes 108
Biotyping of pathogenic fungi by the killer system and with monoclonal antibodies. 107
Relazione struttura-funzione di un peptide fungicida derivato dalla regione costante di immunoglobuline G umane 107
Caratterizzazione dell'amikacina-resistenza in Acinetobacter calcoaceticus varietà anitratus. 106
Human natural yeast killer toxin-like antibodies 106
Reversible self-assembly: A key feature for a new class of autodelivering therapeutic peptides 106
Antibiotic assay-based treatment of Helicobacter Pylori ( HP ) infection. 106
Protective antifungal yeast killer toxin-like antibodies 104
Ogni frammento anticorpale può esplicare attività antinfettiva ed antitumorale. 104
L'automazione integrata nel Laboratorio di Batteriologia. 104
In vitro activity of monoclonal and recombinant yeast killer toxin-like antibodies against antibiotic-resistant Gram-positive cocci 102
Single residue contribution to self-aggregation of a fungicidal immunoglobulin-derived peptide 102
Reliability of the bacterial identification tests and of antibiotic sensitivity tests made with automatic methods. 101
Totale 14.235
Salva come PNG Salva come JPEG
Categoria #
all - tutte 117.588
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 117.588
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021450 0 0 0 0 0 0 0 0 0 46 352 52
2021/20221.638 27 4 17 62 52 86 226 300 66 109 157 532
2022/20234.451 594 381 220 287 474 513 28 230 1.571 18 91 44
2023/20241.528 92 163 83 40 136 427 41 72 25 79 126 244
2024/20255.546 48 415 404 285 412 536 157 193 946 602 380 1.168
2025/202611.896 1.015 1.300 1.546 1.603 1.696 601 1.601 438 1.495 601 0 0
Totale 35.017